These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33307936)

  • 1. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.
    Divino V; Ramasamy A; Anupindi VR; Eriksen KT; Olsen AH; DeKoven M; Meincke HH
    J Manag Care Spec Pharm; 2021 Feb; 27(2):210-222. PubMed ID: 33307936
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States.
    Li Q; Blume SW; Huang JC; Hammer M; Ganz ML
    J Med Econ; 2015; 18(12):1020-8. PubMed ID: 26134917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year progression of obesity-related complications in a population with overweight and obesity in the UK: A retrospective open cohort study.
    Pearson-Stuttard J; Holloway S; Sommer Matthiessen K; Thompson A; Capucci S
    Diabetes Obes Metab; 2024 Nov; 26(11):5056-5064. PubMed ID: 39159940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic value of nonsurgical weight loss in adults with obesity.
    Ding Y; Fan X; Blanchette CM; Smolarz BG; Weng W; Ramasamy A
    J Manag Care Spec Pharm; 2021 Jan; 27(1):37-50. PubMed ID: 33164723
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Weight Change on Economic Outcomes Among Persons with Type 2 Diabetes Mellitus in the United States: Beyond Glycemic Control.
    Karkare S; Fridman M; Dang-Tan T; Lu J; Smolarz BG; DeKoven M; Iyer NN
    J Manag Care Spec Pharm; 2019 Jun; 25(6):658-668. PubMed ID: 30730232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals.
    Pearson-Stuttard J; Banerji T; Capucci S; de Laguiche E; Faurby MD; Haase CL; Sommer Matthiessen K; Near AM; Tse J; Zhao X; Evans M
    Int J Obes (Lond); 2023 Dec; 47(12):1239-1246. PubMed ID: 37723273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in healthcare costs by body mass index and obesity-related complications in a UK population: A retrospective open cohort study.
    Pearson-Stuttard J; Holloway S; Sommer Matthiessen K; Thompson A; Capucci S
    Diabetes Obes Metab; 2024 Nov; 26(11):5036-5045. PubMed ID: 39159938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical and Economic Burdens of Obesity and the Value of Weight Loss for an EMR-Derived US Cohort: A Modeling Study.
    Toliver J; Schnecke V; Rizkallah L
    Popul Health Manag; 2024 Jun; 27(5):300-306. PubMed ID: 39110141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.
    Hong YD; Onukwugha E; Slejko JF
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1353-1362. PubMed ID: 32996389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight-year trends in obesity-related complications and health care cost progression in a US population with obesity: A retrospective cohort study.
    Evans M; Anupindi VR; DeKoven M; de Laguiche E; Divino V; Faurby MD; Haase CL; Sommer Matthiessen K; Pearson-Stuttard J
    Diabetes Obes Metab; 2023 Feb; 25(2):536-544. PubMed ID: 36263756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
    Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
    Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
    Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of body mass index on surgical outcomes, narcotics consumption, and hospital costs following anterior cervical discectomy and fusion.
    Narain AS; Hijji FY; Haws BE; Kudaravalli KT; Yom KH; Markowitz J; Singh K
    J Neurosurg Spine; 2018 Feb; 28(2):160-166. PubMed ID: 29192877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of obesity in Kuwait: a micro-costing study evaluating the burden of obesity-related comorbidities.
    Al-Sabah S; ElShamy A; Jois S; Low K; Gras A; Gulnar EP
    J Med Econ; 2023; 26(1):1368-1376. PubMed ID: 37853705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct medical costs of obesity in the United States and the most populous states.
    Cawley J; Biener A; Meyerhoefer C; Ding Y; Zvenyach T; Smolarz BG; Ramasamy A
    J Manag Care Spec Pharm; 2021 Mar; 27(3):354-366. PubMed ID: 33470881
    [No Abstract]   [Full Text] [Related]  

  • 16. Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.
    Ford JH; Schroeder K; Nyhuis AW; Foster SA; Aurora SK
    J Manag Care Spec Pharm; 2019 Jan; 25(1):46-59. PubMed ID: 30044691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched Comparison Examining the Effect of Obesity on Clinical, Economic, and Humanistic Outcomes in Patients with Bipolar I Disorder.
    Doane MJ; Jauregui A; Panchmatia HR
    Adv Ther; 2024 Oct; 41(10):3807-3819. PubMed ID: 39115592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
    Wei W; Gandhi K; Blauer-Peterson C; Johnson J
    J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
    Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.